Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach

Analytical Biochemistry

Volumn 414, Issue 2, 2011, Pages 215-225

  Bartolini, Manuela ^a   Naldi, Marina ^a   Fiori, Jessica ^a   Valle, Francesco ^b   Biscarini, Fabio ^b   Nicolau, Dan V ^c   Andrisano, Vincenza ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Amyloid beta peptide; Atomic force microscopy; MALDI TOF mass spectrometry; Myricetin; Self aggregation

Indexed keywords

ATOMIC FORCE MICROSCOPY; DESORPTION; ELECTROSPRAY IONIZATION; FLAVONOIDS; FLUORESCENCE; FLUORESCENCE MICROSCOPY; FLUORESCENCE SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MASS SPECTROMETRY; MORPHOLOGY; OLIGOMERS; PEPTIDES;

AMYLOID-BETA PEPTIDES; KINETIC CHARACTERIZATION; MALDI-TOF MASS SPECTROMETRY; MATRIX-ASSISTED LASER DESORPTION/IONIZATION TIME OF FLIGHTS; MOLECULAR WEIGHT DETERMINATION; MYRICETIN; QUADRUPOLE-TIME OF FLIGHTS; SELF AGGREGATION;

GLYCOPROTEINS;

AMYLOID BETA PROTEIN[1-42]; MONOMER; MYRICETIN; OLIGOMER; THIOFLAVINE;

ARTICLE; ATOMIC FORCE MICROSCOPY; ELECTROSPRAY; FLUORESCENCE SPECTROSCOPY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; MORPHOLOGY; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; TIME OF FLIGHT MASS SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 79956077074     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2011.03.020     Document Type: Article

References (59)

1. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard, J.D. Buxbaum, Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline, JAMA 283 (2000) 1571-1577. (Pubitemid 30161512)
2. D.J. Selkoe, Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid β-protein, J. Alzheimer's Dis. 3 (2001) 75-80.
3. D.J. Selkoe, Translating cell biology into therapeutic advances in Alzheimer's disease, Nature 399 (1999) A23-A31.
4. M.A. Findeis, The role of amyloid beta peptide 42 in Alzheimer's disease, Pharmacol. Ther. 116 (2007) 266-286.
5. D. Scheuner, C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T.D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. Levy-Lahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, S. Younkin, Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nat. Med. 2 (1996) 864-870.
6. T. Luhrs, C. Ritter, M. Adrian, D. Riek-Loher, B. Bohrmann, H. Dobeli, D. Schubert, R. Riek, 3D structure of Alzheimer's amyloid-β (1-42) fibrils, Proc. Natl. Acad. Sci. USA 102 (2005) 17342-17347.
7. D.M. Walsh, D.J. Selkoe, Oligomers on the bra, in: The emerging role of soluble protein aggregates in neurodegeneration, Protein Pept. Lett. 11 (2004) 213-228. (Pubitemid 38689025)
8. C.G. Glabe, R. Kayed, Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis, Neurology 66 (2006) S74-S78. (Pubitemid 43739989)
9. M.P. Lambert, A.K. Barlow, B.A. Chromy, C. Edwards, R. Freed, M. Liosatos, T.E. Morgan, I. Rozovsky, B. Trommer, K.L. Viola, P. Wals, C. Zhang, C.E. Finch, G.A. Krafft, W.L. Klein, Diffusible nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins, Proc. Natl. Acad. Sci. USA 95 (1998) 6448-6453.
10. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, D.J. Selkoe, Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo, Nature 416 (2002) 535-539. (Pubitemid 34288854)
11. S. Varadarajan, S. Yatin, M. Aksenova, D.A. Butterfield, Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity [review], J. Struct. Biol. 130 (2000) 184-208.
12. M. Sandal, F. Valle, I. Tessari, S. Mammi, E. Bergantino, F. Musiani, M. Brucale, L. Bubacco, B. Samori, Conformational equilibria in monomeric ββ-synuclein at the single-molecule level, PLoS Biol. 6 (2008) e6.
13. P. Hortschansky, V. Schroeckh, T. Christopeit, G. Zandomeneghi, M. Fandrich, The aggregation kinetics of Alzheimer's β-amyloid peptide is controlled by stochastic nucleation, Protein Sci. 14 (2005) 1753-1759. (Pubitemid 40994145)
14. M. Necula, R. Kayed, S. Milton, C.G. Glabe, Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct, J. Biol. Chem. 282 (2007) 10311-10324.
15. M. Zhu, S. Han, F. Zhou, S.A. Carter, A.L. Fink, Annular oligomeric amyloid intermediates observed by in situ atomic force microscopy, J. Biol. Chem. 279 (2004) 24452-24459.
16. S.A. Moore, T.N. Huckerby, G.L. Gibson, N.J. Fullwood, S. Turnbull, B.J. Tabner, O.M. El-Agnaf, D. Allsop, Both the D-(+) and L-(-) enantiomers of nicotine inhibit Aβ aggregation and cytotoxicity, Biochemistry 43 (2004) 819-826. (Pubitemid 38114070)
17. T. Kihara, S. Shimohama, A. Akaike, Effects of nicotinic receptor agonists on β-amyloid β-sheet formation, Jpn. J. Pharmacol. 79 (1999) 393-396.
18. M. Bartolini, C. Bertucci, M.L. Bolognesi, A. Cavalli, C. Melchiorre, V. Andrisano, Insight into the kinetic of amyloid beta (1-42) peptide self-aggregation: Elucidation of inhibitors' mechanism of action, Chem. Bio. Chem. 8 (2007) 2152-2161.
19. D.A. Middleton, Solid-state NMR spectroscopy as a tool for drug design: From membrane-embedded targets to amyloid fibrils, Biochem. Soc. Trans. 35 (2007) 985-990. (Pubitemid 350206410)
20. H. Inouye, D.A. Kirschner, Alzheimer's β-amyloid: Insights into fibril formation and structure from Congo red binding, Subcell. Biochem. 38 (2005) 203-224.
21. H. Naiki, F. Gejyo, Kinetic analysis of amyloid fibril formation, Methods Enzymol. 309 (1999) 305-318. (Pubitemid 29446457)
22. D.H. Anderson, K.C. Talaga, A.J. Rivest, E. Barron, G.S. Hageman, L.V. Johnson, Characterization of beta amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration, Exp. Eye Res. 78 (2004) 243-256.
23. G. Bitan, E.A. Fradinger, S.M. Spring, D.B. Teplow, Neurotoxic protein oligomers: What you see is not always what you get, Amyloid 12 (2005) 88-95. (Pubitemid 40978716)
24. X.P. Wang, J.H. Zhang, Y.J. Wang, Y. Feng, X. Zhang, X.X. Sun, J.L. Li, X.T. Du, M.P. Lambert, S.G. Yang, M. Zhao, W.L. Klein, R.T. Liu, Conformation-dependent single-chain variable fragment antibodies specifically recognize β-amyloid oligomers, FEBS Lett. 583 (2009) 579-584.
25. C. Goldsbury, P. Frey, V. Olivieri, U. Aebi, S.A. Muller, Multiple assembly pathways underlie amyloid-β fibril polymorphisms, J. Mol. Biol. 352 (2005) 282-298.
26. N. Benseny-Cases, M. Cocera, J. Cladera, Conversion of non-fibrillar β-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation, Biochem. Biophys. Res. Commun. 361 (2007) 916-921. (Pubitemid 47263455)
27. I. Tessari, M. Bisaglia, F. Valle, B. Samori, E. Bergantino, S. Mammi, L. Bubacco, The reaction of ββ-synuclein with tyrosinase: Possible implications for Parkinson disease, J. Biol. Chem. 283 (2008) 16808-16817.
28. M. Arimon, I. Diez-Perez, M.J. Kogan, N. Durany, E. Giralt, F. Sanz, X. Fernandez-Busquets, Fine structure study of Aβ1-42 fibrillogenesis with atomic force microscopy, FASEB J. 19 (2005) 1344-1346. (Pubitemid 41113744)
29. G. Drochioiu, M. Manea, M. Dragusanu, M. Murariu, E.S. Dragan, B.A. Petre, G. Mezo, M. Przybylski, Interaction of β-amyloid(1-40) peptide with pairs of metal ions: An electrospray ion trap mass spectrometric model study, Biophys. Chem. 144 (2009) 9-20.
30. W.B. Stine Jr., S.W. Snyder, U.S. Ladror, W.S. Wade, M.F. Miller, T.J. Perun, T.F. Holzman, G.A. Krafft, The nanometer-scale structure of amyloid-β visualized by atomic force microscopy, J. Protein Chem. 15 (1996) 193-203. (Pubitemid 3040251)
31. J. Vesenka, M. Guthold, C.L. Tang, D. Keller, E. Delaine, C. Bustamante, Substrate preparation for reliable imaging of DNA molecules with the scanning force microscope, Ultramicroscopy 42-44 (1992) 1243-1249.
32. M. Yang, D.B. Teplow, Amyloid b-protein monomer folding: Free-energy surfaces reveal alloform-specific differences, J. Mol. Biol. 384 (2008) 450-464.
33. R. Roychaudhuri, M. Yang, M.M. Hoshi, D.B. Teplow, Amyloid β-protein assembly and Alzheimer disease, J. Biol. Chem. 284 (2009) 4749-4753.
34. A. Parbhu, H. Lin, J. Thimm, R. Lal, Imaging real-time aggregation of amyloid beta protein (1-42) by atomic force microscopy, Peptides 23 (2002) 1265-1270.
35. J.D. Harper, S.S. Wong, C.M. Lieber, P.T. Lansbury Jr., Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease, Biochemistry 38 (1999) 8972-8980.
36. M.P. Lambert, K.L. Viola, B.A. Chromy, L. Chang, T.E. Morgan, J. Yu, D.L. Venton, G.A. Krafft, C.E. Finch, W.L. Klein, Vaccination with soluble Aβ oligomers generates toxicity-neutralizing antibodies, J. Neurochem. 79 (2001) 595-605. (Pubitemid 33029933)
37. J.D. Harper, S.S. Wong, C.M. Lieber, P.T. Lansbury, Observation of metastable Aβ amyloid protofibrils by atomic force microscopy, Chem. Biol. 4 (1997) 119-125.
38. B. Urbanc, M. Betnel, L. Cruz, G. Bitan, D.B. Teplow, Elucidation of amyloid β-protein oligomerization mechanisms: Discrete molecular dynamics study, J. Am. Chem. Soc. 132 (2010) 4266-4280.
39. M. Groenning, L. Olsen, M. van de Weert, J.M. Flink, S. Frokjaer, F.S. Jorgensen, Study on the binding of thioflavin T to β-sheet-rich and non-β-sheet cavities, J. Struct. Biol. 158 (2007) 358-369.
40. H. Naiki, K. Higuchi, M. Hosokawa, T. Takeda, Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1, Anal. Biochem. 177 (1989) 244-249. (Pubitemid 19088253)
41. S.L. Bernstein, T. Wyttenbach, A. Baumketner, J.E. Shea, G. Bitan, D.B. Teplow, M.T. Bowers, Amyloid β-prote, in: Monomer structure and early aggregation states of Aβ42 and its Pro19 alloform, J. Am. Chem. Soc. 127 (2005) 2075-2084.
42. D.M. Walsh, D.M. Hartley, Y. Kusumoto, Y. Fezoui, M.M. Condron, A. Lomakin, G.B. Benedek, D.J. Selkoe, D.B. Teplow, Amyloid β-protein fibrillogenesis: Structure and biological activity of protofibrillar intermediates, J. Biol. Chem. 274 (1999) 25945-25952.
43. J.D. Harper, C.M. Lieber, P.T. Lansbury Jr., Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein, Chem. Biol. 4 (1997) 951-959.
44. D.M. Walsh, A. Lomakin, G.B. Benedek, M.M. Condron, D.B. Teplow, Amyloid β-protein fibrillogenesis: Detection of a protofibrillar intermediate, J. Biol. Chem. 272 (1997) 22364-22372.
45. I.A. Mastrangelo, M. Ahmed, T. Sato, W. Liu, C. Wang, P. Hough, S.O. Smith, High-resolution atomic force microscopy of soluble A842 oligomers, J. Mol. Biol. 358 (2006) 106-119.
46. G. Bitan, M.D. Kirkitadze, A. Lomakin, S.S. Vollers, G.B. Benedek, D.B. Teplow, Amyloid β-protein (Aβ) assembly: Aβ 40 and Aβ 42 oligomerize through distinct pathways, Proc. Natl. Acad. Sci. USA 100 (2003) 330-335.
47. G. Bitan, Structural study of metastable amyloidogenic protein oligomers by photo-induced cross-linking of unmodified proteins, Methods Enzymol. 413 (2006) 217-236. (Pubitemid 44528693)
48. R. Kayed, E. Head, J.L. Thompson, T.M. McIntire, S.C. Milton, C.W. Cotman, C.G. Glabe, Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis, Science 300 (2003) 486-489. (Pubitemid 36444329)
49. M. Masuda, N. Suzuki, S. Taniguchi, T. Oikawa, T. Nonaka, T. Iwatsubo, S. Hisanaga, M. Goedert, M. Hasegawa, Small molecule inhibitors of ββ-synuclein filament assembly, Biochemistry 45 (2006) 6085-6094. (Pubitemid 43727101)
50. J.P. Cleary, D.M. Walsh, J.J. Hofmeister, G.M. Shankar, M.A. Kuskowski, D.J. Selkoe, K.H. Ashe, Natural oligomers of the amyloid-β protein specifically disrupt cognitive function, Nat. Neurosci. 8 (2005) 79-84.
51. L. Hamon, D. Panda, P. Savarin, V. Joshi, J. Bernhard, E. Mucher, A. Mechulam, P.A. Curmi, D. Pastre, Mica surface promotes the assembly of cytoskeletal proteins, Langmuir 25 (2009) 3331-3335.
52. S.S. Durairajan, Q. Yuan, L. Xie, W.S. Chan, W.F. Kum, I. Koo, C. Liu, Y. Song, J.D. Huang, W.L. Klein, M. Li, Salvianolic acid B inhibits Aβ fibril formation and disaggregates preformed fibrils and protects against Aβ-induced cytotoxicty, Neurochem. Intl. 52 (2008) 741-750.
53. J.H. Byun, H. Kim, Y. Kim, I. Mook-Jung, D.J. Kim, W.K. Lee, K.H. Yoo, Aminostyrylbenzofuran derivatives as potent inhibitors for Aβ fibril formation, Bioorg. Med. Chem. Lett. 18 (2008) 5591-5593.
54. S.R. Byeon, J.H. Lee, J.H. Sohn, D.C. Kim, K.J. Shin, K.H. Yoo, I. Mook-Jung, W.K. Lee, D.J. Kim, Bis-styrylpyridine and bis-styrylbenzene derivatives as inhibitors for Aβ fibril formation, Bioorg. Med. Chem. Lett. 17 (2007) 1466-1470. (Pubitemid 46240822)
55. M. Sakono, T. Zako, Amyloid oligomers: Formation and toxicity of Aβ oligomers, FEBS J. 277 (2010) 1348-1358.
56. K. Ono, Y. Yoshiike, A. Takashima, K. Hasegawa, H. Naiki, M. Yamada, Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: Implications for the prevention and therapeutics of Alzheimer's disease, J. Neurochem. 87 (2003) 172-181. (Pubitemid 37210651)
57. T. Hamaguchi, K. Ono, A. Murase, M. Yamada, Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-β aggregation pathway, Am. J. Pathol. 175 (2009) 2557-2565.
58. Y. Shimmyo, T. Kihara, A. Akaike, T. Niidome, H. Sugimoto, Multifunction of myricetin on Aβ: Neuroprotection via a conformational change of Aβ and reduction of Aβ via the interference of secretases, J. Neurosci. Res. 86 (2008) 368-377.
59. M. Bartolini, V. Andrisano, Strategies for the inhibition of protein aggregation in human diseases, ChemBioChem. 11 (2010) 1018-1035.